Phototoxicity─Medicinal Chemistry Strategies for Risk Mitigation in Drug Discovery
- 14 July 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (14) , 9345-9362
Abstract
Phototoxicity is a common safety concern encountered by project teams in pharmaceutical research and has the potential to stop progression of an otherwise promising candidate molecule. This perspective aims to provide an overview of the approaches toward mitigation of phototoxicity that medicinal chemists have taken during the lead optimization phase in the context of regulatory standards for photosafety evaluation. Various strategies are laid out based on available literature examples in order to highlight how structural modification can be utilized toward successful mitigation of a phototoxicity liability. A proposed flowchart is presented as a guidance tool to be used by the practicing medicinal chemist when facing a phototoxicity risk. The description of available tools to consider in the drug design process will include an overview of the evolution of in silico methods and their application as well as structure alerts for consideration as potential phototoxicophores.Keywords
This publication has 71 references indexed in Scilit:
- The 3T3 neutral red uptake phototoxicity test: Practical experience and implications for phototoxicity testing – The report of an ECVAM–EFPIA workshopRegulatory Toxicology and Pharmacology, 2012
- Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticityDrug Discovery Today, 2011
- Synthesis and Antibacterial Activity of Novel Pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic Acid Derivatives Carrying the 3-Cyclopropylaminomethyl-4-substituted-1-pyrrolidinyl Group as a C-10 SubstituentJournal of Medicinal Chemistry, 2008
- New Findings on the Structure-Phototoxicity Relationship and Photostability of Fluoroquinolones with Various Substituents at Position 1Antimicrobial Agents and Chemotherapy, 2004
- Drug-Induced Cutaneous PhotosensitivityDrug Safety, 2002
- Photochemistry of 2-Hydroxy-4-trifluoromethylbenzoic Acid, Major Metabolite of the Photosensitizing Platelet Antiaggregant Drug Triflusal¶Photochemistry and Photobiology, 2001
- Phototoxicity Associated with Diclofenac: A Photophysical, Photochemical, and Photobiological Study on the Drug and Its PhotoproductsChemical Research in Toxicology, 1998
- Fluoroquinolone Antimicrobials: Singlet Oxygen, Superoxide and PhototoxicityPhotochemistry and Photobiology, 1998
- Support-vector networksMachine Learning, 1995
- A COMPARATIVE STUDY OF THE PHOTOCHEMISTRY OF THE NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS, NAPROXEN, BENOXAPROFEN AND INDOMETHACINPhotochemistry and Photobiology, 1988